Bio Essence Corp
BIOE· OTC
Filed Mar 30, 2023 · 10-K · 89 days after period end · 0001213900-23-024571
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|---|
| Revenue | — | $213.04K | $218.93K |
| Net Income | -$213.13K | -$90.63K | -$89.54K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio Essence Corp · CIK 1723059 · Engraved from SEC EDGAR
ended Dec 31, 2022 · filed Mar 30, 2023 · 89 d after period end